Brain-computer interfaces — devices that create a direct communication pathway between the human brain and external computers — are transitioning from science fiction to clinical reality at a pace that is surprising even the researchers working in the field. Three companies are leading the race to commercialize this technology: Neuralink, founded by Elon Musk; Synchron, backed by Bill Gates and Jeff Bezos; and BrainGate, a research consortium based at Brown University. Each is taking a different technical approach, and each has achieved remarkable results in early human trials.
Neuralink — The Ambitious Newcomer
Neuralink has implanted its N1 chip in three human patients with severe paralysis, allowing them to control computers and smartphones using only their thoughts. The N1 chip contains 1,024 electrodes that record neural activity from thousands of neurons simultaneously — far more than any previous brain-computer interface. The device is implanted by a surgical robot that places the electrodes with precision that exceeds human surgical capability, minimizing tissue damage and maximizing signal quality.
The first Neuralink patient, Noland Arbaugh, who was paralyzed from the shoulders down following a diving accident, demonstrated the device by playing chess and video games using only his thoughts. He described the experience as feeling like using a Force power from Star Wars — thinking about moving a cursor and watching it move on screen. Subsequent patients have achieved even higher performance, with one patient achieving a typing speed of 90 characters per minute using thought alone.
Synchron — The Less Invasive Alternative
Synchron has taken a different approach with its Stentrode device, which is implanted through a blood vessel rather than requiring open brain surgery. The device is delivered through the jugular vein and positioned in a blood vessel adjacent to the motor cortex, where it records neural signals through the vessel wall. While this approach captures fewer neurons than Neuralink direct implant, it is significantly safer and can be performed under local anesthesia.
Synchron has implanted its device in 10 patients across the United States and Australia, all with severe motor neuron disease. Patients have used the device to send text messages, browse the internet, and control smart home devices using thought alone. One patient sent the first thought-to-text message in history, typing I am not afraid using only his brain signals.
Ethical and Social Implications
The rapid progress of brain-computer interfaces raises profound ethical questions. Who owns the neural data generated by these devices? Can employers or governments require employees or citizens to use BCIs? What happens when BCIs are hacked? How do we ensure that this technology is accessible to all who need it, not just the wealthy? These questions are being actively debated by ethicists, policymakers, and disability rights advocates, and the answers will shape how this transformative technology is developed and deployed.
